Cytokinetics, Incorporated earnings per share and revenue

CYTK earnings per share for the last quarter are -1.33 USD whereas the estimation was -1.14 USD which accounts for -16.29% surprise. Company revenue for the same period amounts to 835.00 k USD despite the estimated figure of 912.85 k USD. Estimated earnings per share for the next quarter are -1.17 USD, and revenue is expected to reach 948.44 k USD. Also watch annual changes over time to get a bigger picture of CYTK earnings per share and revenue dynamics.